eFit Financial Pricing Overview
eFit Financial Pricing Key Insights
Last updated on Apr 09, 2026
Information about eFit Financial pricing, plan availability, and costs is not listed on G2 by the vendor. Buyers typically need to engage directly with the vendor to understand pricing options. Final cost negotiations to purchase eFit Financial must be conducted with the seller.
Top-Rated Alternatives
eFit Financial Alternatives Pricing
The following is a quick overview of editions offered by other Professional Association Management Software
| Product | Price | Features |
|---|---|---|
 Essentials |
Free Trial10 Users Per Year |
Foundation boards require for a complete meeting cycle with core tools for secure agendas, books, and meetings.
|
 Neon CRM |
Starting at $99.00Per Month |
Get all the donor management, fundraising, and communication tools you need to turn individual data points into personal connections that drive sustainable growth.
|
 Basic |
$150.00With One-Time Purchase |
Basic setup includes full support during setup period and importing your member and non-member databases.
|
Various alternatives pricing & plans
Pricing information for the above various eFit Financial alternatives is supplied by the respective software provider or retrieved from publicly accessible pricing materials. Final cost negotiations to purchase any of these products must be conducted with the seller.
Categories on G2
Explore More
Which display advertising software has the best creative production workflow for high-volume campaigns?Which app localization vendors offer transparent workflows and real-time visibility into project and task status?Which Google Workspace utilities have the strongest bulk operation features for onboarding and offboarding workflows?
We're choosing between TrueContext, Poka.io and Dozuki, has anyone actually rolled one of these out across multiple plants and can speak to frontline adoption?Most reliable network monitoring solution for large corporationsWhich pharmacy management systems are most reliable based on reviews from pharmacy directors at growing pharmacy companies?